These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 23731644)

  • 1. Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: systematic review and meta-analysis of observational studies.
    Salgado E; Maneiro JR; Carmona L; Gómez-Reino J
    Joint Bone Spine; 2014 Jan; 81(1):41-50. PubMed ID: 23731644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.
    Sode J; Vogel U; Bank S; Andersen PS; Thomsen MK; Hetland ML; Locht H; Heegaard NH; Andersen V
    PLoS One; 2014; 9(6):e100361. PubMed ID: 24967817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF Alpha and Risk of Lymphoma in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    Imam AA
    Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064585
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of anti-TNF-α biologics on insulin resistance and insulin sensitivity in patients with rheumatoid arthritis: An update systematic review and meta-analysis.
    Lim WS; Teoh SE; Tang ASP; Tan BJM; Lee JY; Yau CE; Thumboo J; Ng QX
    Diabetes Metab Syndr; 2024 Apr; 18(4):103001. PubMed ID: 38604059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Dysregulated Central Pain Processing and Response to Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis.
    Heisler AC; Song J; Muhammad LN; Wohlfahrt A; Marder W; Bolster MB; Bingham CO; Clauw DJ; Dunlop DD; Neogi T; Lee YC
    Arthritis Rheumatol; 2020 Dec; 72(12):2017-2024. PubMed ID: 32683800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Rheumatoid Factor, Rheumatoid Arthritis, and Interleukin-6 Inhibitor with the Prognosis of Ischemic Stroke: a Prospective Multicenter Cohort Study and Mendelian Randomization Analysis.
    Jia Y; Zhang K; Shi M; Guo D; Yang P; Bu X; Chen J; Wang A; Xu T; He J; Zhu Z; Zhang Y
    Transl Stroke Res; 2024 Aug; 15(4):750-760. PubMed ID: 37256492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.
    Mankia K; Siddle HJ; Kerschbaumer A; Alpizar Rodriguez D; Catrina AI; Cañete JD; Cope AP; Daien CI; Deane KD; El Gabalawy H; Finckh A; Holers VM; Koloumas M; Ometto F; Raza K; Zabalan C; van der Helm-van Mil A; van Schaardenburg D; Aletaha D; Emery P
    Ann Rheum Dis; 2021 Oct; 80(10):1286-1298. PubMed ID: 34362746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of ineffectiveness of biological drugs using machine learning and explainable AI methods: data from the Austrian Biological Registry BioReg.
    Ukalovic D; Leeb BF; Rintelen B; Eichbauer-Sturm G; Spellitz P; Puchner R; Herold M; Stetter M; Ferincz V; Resch-Passini J; Zwerina J; Zimmermann-Rittereiser M; Fritsch-Stork R
    Arthritis Res Ther; 2024 Feb; 26(1):44. PubMed ID: 38331930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the serological status of rheumatoid arthritis patients with two circulating protein biomarkers: A useful tool for precision medicine strategies.
    Ruiz-Romero C; Fernández-Puente P; González L; Illiano A; Lourido L; Paz R; Quaranta P; Perez-Pampín E; González A; Blanco FJ; Calamia V
    Front Med (Lausanne); 2022; 9():963540. PubMed ID: 36388911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study.
    Naffaa ME; Hassan F; Golan-Cohen A; Merzon E; Green I; Saab A; Paz Z
    Rheumatol Int; 2021 Nov; 41(11):1905-1913. PubMed ID: 34529109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in Rheumatoid Arthritis - Laboratory and Clinical Perspectives.
    Rönnelid J; Turesson C; Kastbom A
    Front Immunol; 2021; 12():685312. PubMed ID: 34054878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry.
    Lin CT; Huang WN; Tsai WC; Chen JP; Hung WT; Hsieh TY; Chen HH; Hsieh CW; Lai KL; Tang KT; Tseng CW; Chen DY; Chen YH; Chen YM
    PLoS One; 2021; 16(4):e0250877. PubMed ID: 33930048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis.
    Liu J; Zhu Q; Han J; Zhang H; Li Y; Ma Y; He D; Gu J; Zhou X; Reveille JD; Jin L; Zou H; Ren S; Wang J
    Mol Med; 2019 Jun; 25(1):25. PubMed ID: 31195969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data.
    RA-MAP Consortium
    RMD Open; 2018; 4(2):e000721. PubMed ID: 30487994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.
    Martin-Mola E; Balsa A; García-Vicuna R; Gómez-Reino J; González-Gay MA; Sanmartí R; Loza E
    Rheumatol Int; 2016 Aug; 36(8):1043-63. PubMed ID: 27271502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study.
    Ortea I; Roschitzki B; López-Rodríguez R; Tomero EG; Ovalles JG; López-Longo J; de la Torre I; González-Alvaro I; Gómez-Reino JJ; González A
    PLoS One; 2016; 11(4):e0153140. PubMed ID: 27050469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease.
    Mohammed RH; Farahat F; Kewan HH; Bukhari MA
    Springerplus; 2015; 4():207. PubMed ID: 25977895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor.
    Aberumand B; Barra L; Cao Y; Riche NL; Thompson AE; Rohekar G; Rohekar S; Bonner A; Pope JE
    Open Rheumatol J; 2014; 8():73-6. PubMed ID: 25352925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid factors: clinical applications.
    Ingegnoli F; Castelli R; Gualtierotti R
    Dis Markers; 2013; 35(6):727-34. PubMed ID: 24324289
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.